:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Dana Al Khalifa, Pascal Chastagner, Gudrun Schleiermacher, Julien Lejeune
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pediatric Blood & Cancer
Online Access:	https://onlinelibrary.wiley.com/doi/10.1002/pbc.32027
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chemo‐Immunotherapy Rescue for High‐Risk Neuroblastoma Patients With Progressive Disease Before High‐Dose Chemotherapy: Real‐World Data From the SACHA‐France Study
by: Claudia Pasqualini, et al.
Published: (2025)

Atypical Neuroblastoma With Absent Urinary Catecholamine Excretion and 123ImIBG Avidity Are of Favorable Outcome: A Retrospective French Single‐Center Study
by: Anna Borovkov, et al.
Published: (2025)

Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group
by: Hetal Dholaria, et al.
Published: (2025)

Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post‐Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group
by: Rebecca J. Deyell, et al.
Published: (2026)

Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project
by: Mallory R. Taylor, et al.
Published: (2025)

Outcomes Based on Histological Tumor Necrosis and Predictive Clinical and Laboratory Parameters for Necrosis in Children With Osteosarcoma Treated on a Non‐High Dose Methotrexate‐Based Chemotherapy Backbone
by: Badira Cheriyalinkal Parambil, et al.
Published: (2024)

Paraneoplastic Lupus Nephritis in a Child With Neuroblastoma Recurrence
by: Gabriele Mortari, et al.
Published: (2026)

Chemotherapy–Surgery Interval Effects on Tumor Necrosis and Outcome in Children and Young Adults With Osteosarcoma
by: Rachel B. Mersfelder, et al.
Published: (2024)

Evaluating the Genetic Overlap Between Congenital Heart Disease and Neuroblastoma Risk
by: Ji Yun Tark, et al.
Published: (2025)

A 2035 Clinical Research Vision and Roadmap for High‐Risk Neuroblastoma
by: Lucas Moreno, et al.
Published: (2025)

Routine Screening for Neuroblastoma in Harlequin Syndrome Without Otherwise Known Etiology
by: Colburn Yu, et al.
Published: (2025)

Evaluation of TRPA1 as a Therapeutic Target in MYCN‐Amplified Neuroblastoma
by: Alexandra Seger, et al.
Published: (2025)

Pancreas, Muscle, and Subcutaneous Fat Atrophy in Patients Undergoing Radiation for Neuroblastoma
by: Pradipta Debnath, et al.
Published: (2026)

Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma
by: Aseel Bzour, et al.
Published: (2025)

Rare EWSR1::PBX1 Fusion‐Positive Infant B‐ALL With Coexisting KRAS Mutation: Sustained Molecular Remission Achieved With Standard Chemotherapy
by: Xiaoyong Chen, et al.
Published: (2025)

Incidence of Adrenal Insufficiency in Patients With High‐Risk Neuroblastoma: A Single‐Institution Analysis
by: Shachi Srivatsa, et al.
Published: (2025)

Neuroblastoma Presenting With Bilateral Renal Artery Obstruction and Thrombotic Microangiopathy: A Case Report
by: Muhammed Bahaddin Ates, et al.
Published: (2025)

A Rare Case of Concurrent Neuroblastoma and Acute Myeloid Leukemia With CBFA2T3::GLIS2 Fusion: A Diagnostic and Therapeutic Dilemma
by: Laura M. Molina, et al.
Published: (2025)

A Rare Case of Infant B‐ALL With SIN3A::NUTM1 Fusion: Durable Molecular Remission Achieved With Standard Acute Lymphoblastic Leukemia Chemotherapy
by: Dong Peng, et al.
Published: (2026)

Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti‐GD2 Monoclonal Antibody Therapy in Patients With Neuroblastoma
by: Wei Wei, et al.
Published: (2025)

A Case of Pediatric Adrenocortical Carcinoma With McCune‐Albright Syndrome Masquerading as Spontaneously Regressing Neuroblastoma
by: Yu Lin, et al.
Published: (2026)

Cognitive Outcomes in Children Treated for Ependymoma Diagnosed Under 36 Months: A Systematic Review
by: Sophie Thomas, et al.
Published: (2025)

Cyclosporine Resolved Late Graft Failure After Autologous Transplantation for Neuroblastoma by Promoting CD4 T‐Cell Recovery
by: Yu Shiguta, et al.
Published: (2026)

Aggressive Pediatric Primitive Round Cell Tumors with MN1::ZNF341 Fusion: A Mimic of Neuroblastoma
by: Serena Y. Tan, et al.
Published: (2024)

Safety and Efficacy of Romiplostim in Maintaining Chemotherapy Interval and Dose Intensity in Pediatric Patients With Solid Tumors and Chemotherapy‐Induced Thrombocytopenia
by: Erica Tonti, et al.
Published: (2026)

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131 I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era
by: Benjamin J. Lerman, et al.
Published: (2026)

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience
by: Thomas J. Jackson, et al.
Published: (2026)

Long‐Term Outcomes and Quality of Life of Children With Intracranial Ependymoma Treated With Pencil Beam Scanning Proton Therapy
by: Eymeric Le Reun, et al.
Published: (2025)

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse
by: Vicente Santa‐Maria Lopez, et al.
Published: (2026)

Retrospective Analysis of Incidence and Etiology of Severe Infections in Children Receiving Therapy for High‐Risk Neuroblastoma: A Large Single‐Center Experience
by: Elio Castagnola, et al.
Published: (2026)

The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor
by: Nils Welter, et al.
Published: (2026)

Life‐Threatening Infantile Fibrosarcoma in an Infant
by: Katharina Daugs, et al.
Published: (2025)

Dabrafenib as a Therapeutic Option for Chemotherapy‐Refractory Pediatric Juvenile Xanthogranuloma
by: Mengxuan Wang, et al.
Published: (2025)

Long‐Term Clinical Outcome and Quality of Life of Children, Adolescents, and Young Adults With Chordoma or Chondrosarcoma Treated With Pencil Beam Scanning Proton Therapy
by: Miriam Vazquez, et al.
Published: (2025)

Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus
by: Negar Shavandi, et al.
Published: (2026)

Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
by: Ashley C. Holland, et al.
Published: (2025)

A Little Known but Very Common Phenotype in Patients With Severe Congenital Neutropenia Due to HAX1 Deficiency: Premature Ovarian Insufficiency
by: Deniz Özalp Kızılay, et al.
Published: (2025)

A nationwide phase II study of delayed local treatment for children with high‐risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN‐H‐11
by: Akihiro Yoneda, et al.
Published: (2024)

Primary Hepatic Choriocarcinoma With Pulmonary Metastasis in an Infant: Diagnosis and Treatment
by: Jie Zhao, et al.
Published: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
by: Mikhail Lemeshev, et al.
Published: (2026)